ClinicalTrials.Veeva

Menu

The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Completed

Conditions

Colorectal Cancer

Treatments

Procedure: ICG Guided surgery
Procedure: conventional surgery

Study type

Observational

Funder types

Other

Identifiers

NCT06508541
2024-06-001

Details and patient eligibility

About

Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging

Enrollment

235 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age > 18 years,
  • confirmed diagnosis of primary CRC,
  • preoperative tumor stage of cT1 to cT4, N-/+, M0 as determined by contrast-enhanced computed tomography (CT),
  • no distant metastasis, -American Society of Anesthesiologists(ASA)Physical Status Classification score of 1, 2, or 3-

Exclusion criteria

  • history of previous colorectal surgery, emergent surgery, or palliative resection;
  • pregnancy or breastfeeding;
  • allergy or history of an adverse reaction to ICG; and
  • severe mental disorder.

Trial design

235 participants in 2 patient groups

conventional surgery
Description:
All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose.
Treatment:
Procedure: conventional surgery
Indocyanine green fluorescence-guided surgery
Description:
Approximately 0.3 ml of ICG dissolved in 2.5 mg/ml of sterile water was injected submucosally by the endoscopic doctors through colonoscopy at two points around the tumor.All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose using ICG lymphangiography procedure
Treatment:
Procedure: conventional surgery
Procedure: ICG Guided surgery

Trial contacts and locations

1

Loading...

Central trial contact

Quanjun Lin; Peng Sun, MD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems